Ellis, Peter M. et al
"Phase I Open-Label Study of Continuous Treatment with BIBF 1120, a Triple Angiokinase Inhibitor, and Pemetrexed in Pretreated Non–Small Cell Lung Cancer Patients." Clinical Cancer Research
16.10
(2010):
2881-2889.
Web. 02 Mar. 2021.
